Specifica Announces Antibody Discovery Platform Transfer Agreement with Sanofi
SANTA FE, N.M.--(BUSINESS WIRE)--Specifica, a privately held antibody engineering company focused on innovative in vitro antibody libraries and discovery tools, today announced an agreement with the global healthcare company Sanofi under…
Andrew BradburyJune 2, 2022